Synthesis, evaluation and structure-activity relationships of triazine dimers as novel antiviral agents.
暂无分享,去创建一个
J. Heeres | P. Lewi | G. Vanham | K. Ariën | P. Van der Veken | J. Joossens | K. Augustyns | Jonas Messagie | M. Venkatraj | J. Míchiels
[1] Robert A. Domaoal,et al. Discovery of dimeric inhibitors by extension into the entrance channel of HIV-1 reverse transcriptase. , 2012, Bioorganic & medicinal chemistry letters.
[2] Christophe M. L. Vande Velde,et al. Novel diarylpyridinones, diarylpyridazinones and diarylphthalazinones as potential HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs). , 2011, Bioorganic & medicinal chemistry.
[3] S. Pelly,et al. Imidazo[1,2-a]pyridin-3-amines as potential HIV-1 non-nucleoside reverse transcriptase inhibitors. , 2011, Bioorganic & medicinal chemistry.
[4] E. De Clercq,et al. A time-of–drug addition approach to target identification of antiviral compounds , 2011, Nature Protocols.
[5] B. Clotet,et al. Diarylpyrimidine-dihydrobenzyloxopyrimidine hybrids: new, wide-spectrum anti-HIV-1 agents active at (sub)-nanomolar level. , 2011, Journal of medicinal chemistry.
[6] Catherine Caillet,et al. Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitors. , 2011, Journal of medicinal chemistry.
[7] Hong Lu,et al. Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. , 2010, Journal of medicinal chemistry.
[8] E. De Clercq,et al. Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy. , 2010, Bioorganic & medicinal chemistry.
[9] Xianfeng Lin,et al. Discovery of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-benzyl derivatives with broad potency against resistant mutant viruses. , 2010, Bioorganic & medicinal chemistry letters.
[10] Hong Lu,et al. Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors. , 2010, Journal of medicinal chemistry.
[11] C. Pannecouque,et al. Synthesis and anti-HIV activity of 2-naphthyl substituted DAPY analogues as non-nucleoside reverse transcriptase inhibitors. , 2010, Bioorganic & medicinal chemistry.
[12] William L. Jorgensen,et al. Eastern extension of azoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase; cyano group alternatives. , 2010, Bioorganic & medicinal chemistry letters.
[13] E. De Clercq,et al. Synthesis and biological evaluation of 4-(hydroxyimino)arylmethyl diarylpyrimidine analogues as potential non-nucleoside reverse transcriptase inhibitors against HIV. , 2010, Bioorganic & Medicinal Chemistry.
[14] Hong Lu,et al. Discovery of diarylpyridine derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. , 2009, Bioorganic & medicinal chemistry letters.
[15] C. Herrera,et al. Reverse Transcriptase Inhibitors as Potential Colorectal Microbicides , 2009, Antimicrobial Agents and Chemotherapy.
[16] D. Stammers,et al. Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase. , 2008, Virus research.
[17] C. Sahlberg,et al. Development of Non-Nucleoside Reverse Transcriptase Inhibitors for Anti- HIV Therapy , 2008 .
[18] K. Hertogs,et al. Synthesis of novel diarylpyrimidine analogues of TMC278 and their antiviral activity against HIV-1 wild-type and mutant strains. , 2007, European journal of medicinal chemistry.
[19] K. Hertogs,et al. Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1. , 2005, Journal of medicinal chemistry.
[20] Stephen H Hughes,et al. In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine). , 2005, Journal of medicinal chemistry.
[21] Bart De Corte,et al. From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125): fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase. , 2005 .
[22] Koen Andries,et al. TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1 , 2004, Antimicrobial Agents and Chemotherapy.
[23] Rudi Pauwels,et al. New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections. , 2004, Current opinion in pharmacology.
[24] H. M. Vinkers,et al. Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. , 2004, Journal of medicinal chemistry.
[25] R. Pauwels,et al. Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues. , 2001, Bioorganic & medicinal chemistry letters.
[26] R. Pauwels,et al. Evolution of anti-HIV drug candidates. Part 2: Diaryltriazine (DATA) analogues. , 2001, Bioorganic & medicinal chemistry letters.
[27] P. Anderson,et al. L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase , 1995, Antimicrobial agents and chemotherapy.
[28] Jianping Ding,et al. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. , 1994, Journal of molecular biology.
[29] L. Resnick,et al. U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication , 1993, Antimicrobial Agents and Chemotherapy.
[30] J. Adams,et al. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. , 1990, Science.
[31] E. De Clercq,et al. Recent advances in DAPYs and related analogues as HIV-1 NNRTIs. , 2011, Current medicinal chemistry.